At a time when the nations of the world were recording about 15,000 COVID deaths per day, Dr. Andrew Hill of the University of Liverpool was about to publish a meta-analysis for the World Health Organization and other leading health agencies indicating the remarkable effectiveness of a repurposed drug in treating COVID-19, reducing hospitalization by some 80%.
But when he published his highly influential pre-print paper on Jan. 18, 2021, his stated conclusion didn’t match the study’s findings.
TRUTH LIVES on at https://sgtreport.tv/
Instead of urging physicians around the world who were desperate for solutions to try the safe and effective drug, Hill wrote: “Ivermectin should be validated in larger appropriately controlled randomized trials before the results are sufficient for review by regulatory authorities.”
The English researcher’s turnabout didn’t go unnoticed.
A colleague, Dr. Tess Lawrie, confronted Hill in a remarkable Zoom video conversation that was recorded and featured in a short documentary produced by Oracle Films.
Lawrie, the director of the Evidence-Based Medicine Consultancy at the University of the Witwatersrand in Bath, England, got Hill to admit that his non-profit sponsors, UNITAID, pressured him to alter his conclusion.
UNITAID bills itself as a “global health agency.” It’s funded by vaccine promoters such as the Bill and Melinda Gates Foundation, which committed $120 million to an expensive ivermectin competitor, a Merck drug called molnupiravir. Some medical scientists have warned that the genotoxic molnupiravir could cause viral mutants and worsen the pandemic.
“I think I’m in a very sensitive position here,” Hill told Lawrie.
She replied, “Lots of people are in sensitive positions; they’re in hospital, in ICUs dying, and they need this medicine.”
It turned out that the University of Liverpool received $40 million from UNITAID just four days before the publication of Hill’s study.
Lawrie noted to Hill that is not a clinician.